Cargando…
SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4 (SMARCA4)-deficient non-small cell lung cancer (dNSCLC) is a rare malignant tumor that originates in the lungs. It occurs more frequently in male smokers, and the epidermal growth factor receptor (EGFR)...
Autores principales: | Sun, Lijun, Fu, Qiong, Chen, Lijiang, Di, Meijuan, Cao, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623088/ https://www.ncbi.nlm.nih.gov/pubmed/37927421 http://dx.doi.org/10.3892/ol.2023.14100 |
Ejemplares similares
-
Clinical characteristics and prognostic analysis of SMARCA4‐deficient non‐small cell lung cancer
por: Liang, Xiyue, et al.
Publicado: (2023) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023) -
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
por: Lin, Yun-Tzu, et al.
Publicado: (2023) -
SMARCA4‐deficient lung tumour that presented with haemoptysis and progressed rapidly
por: Inoue, Mari, et al.
Publicado: (2020) -
Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
por: Naito, Tomoyuki, et al.
Publicado: (2019)